US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 522 actively recruiting studies with Ohio sites out of 522 registered in total. The busiest research areas in Ohio are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include Ohio State University, Children's Hospital Medical Center, Cincinnati, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (98), Phase 2 (162), Phase 3 (125), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
522
Recruiting Now
522
← Back to US Map
Top Conditions in Ohio
Prostate Cancer (9)Breast Cancer (9)Ovarian Cancer (8)Endometrial Cancer (7)Acute Myeloid Leukemia (6)Solid Tumor (6)Pancreatic Cancer (5)Heart Failure (5)Multiple Myeloma (5)Colorectal Cancer (5)Advanced Solid Tumor (5)Stroke (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 522 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 522. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT06834165 Phase 4
Recruiting
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in ...
Condition
Allergic Reactions
Enrollment
600 pts
Location
United States
Sponsor
ARS Pharmaceuticals, Inc.
View Trial →
NCT03817502 Phase 3
Recruiting
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (...
Condition
Schizophrenia
Enrollment
330 pts
Location
United States, Bulgaria, Colombia
Sponsor
Gedeon Richter Plc.
View Trial →
NCT05691465 Phase 2
Recruiting
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 1...
Condition
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation
Enrollment
35 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06632977 Phase 2
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
474 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06026657 Phase 1, Phase 2
Recruiting
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
42 pts
Location
United States
Sponsor
Margaret Gatti-Mays
View Trial →
NCT06195072 Phase 2
Recruiting
Platform Clinical Study for Conquering Scleroderma
Condition
Interstitial Lung Disease Due to Systemic Disease
Enrollment
400 pts
Location
United States
Sponsor
Scleroderma Research Foundatio
View Trial →
NCT04565795 N/A
Recruiting
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Ste...
Condition
Ureteral Diseases
Enrollment
87 pts
Location
United States
Sponsor
Adva-Tec
View Trial →
NCT06489301 N/A
Recruiting
Mechanisms for Laser-Induced Rejuvenation
Condition
Skin Cancer
Enrollment
12 pts
Location
United States
Sponsor
Wright State University
View Trial →
NCT06423430 N/A
Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Condition
Treatment Resistant Depression
Enrollment
100 pts
Location
United States
Sponsor
Abbott Medical Devices
View Trial →
NCT04635657 N/A
Recruiting
Cognitive Status After Removal of Skull Base Meningioma
Condition
Meningioma
Enrollment
50 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT06649201 N/A
Recruiting
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
Condition
Graft Vs Host Disease
Enrollment
40 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT05654922 Phase 3
Recruiting
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progress...
Condition
Pre-Bronchiolitis Obliterans Syndrome
Enrollment
100 pts
Location
United States
Sponsor
Renovion, Inc.
View Trial →
NCT07549022 Phase 1, Phase 2
Recruiting
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve She...
Condition
Malignant Peripheral Nerve Sheath Tumors
Enrollment
17 pts
Location
United States
Sponsor
Ankit Mangla, MD
View Trial →
NCT07406633 Phase 2
Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIS...
Condition
GIST - Gastrointestinal Stromal Tumor
Enrollment
46 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT07484217 Phase 3
Recruiting
Clinical Assessment of Response in the Treatment of Depression With Daytime Slee...
Condition
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Enrollment
508 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT07003425 Phase 2
Recruiting
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Condition
Atopic Dermatitis
Enrollment
350 pts
Location
United States, Canada, Czechia
Sponsor
Apogee Therapeutics, Inc.
View Trial →
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT02493478 N/A
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Condition
Failed or Difficult Intubation, Sequela
Enrollment
150,000 pts
Location
United States, Australia, Austria
Sponsor
Children's Hospital of Philade
View Trial →
NCT06964685 N/A
Recruiting
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarctio...
Condition
AMI Cardiogenic Shock
Enrollment
350 pts
Location
United States
Sponsor
Abiomed Inc.
View Trial →
NCT06810518 N/A
Recruiting
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stoo...
Condition
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Enrollment
1,000 pts
Location
United States
Sponsor
American Laboratory Products C
View Trial →
NCT07377747 N/A
Recruiting
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Res...
Condition
Retroperitoneal Liposarcoma
Enrollment
100 pts
Location
United States, Australia, Belgium
Sponsor
Australia and New Zealand Sarc
View Trial →
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06946368 N/A
Recruiting
Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surg...
Condition
Total Knee Arthroplasty
Enrollment
60 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06718491 N/A
Recruiting
Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD
Condition
Opioid Use Disorder
Enrollment
80 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT05065216 Phase 2, Phase 3
Recruiting
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Condition
Acute Stroke
Enrollment
728 pts
Location
United States, Belgium, Canada
Sponsor
DiaMedica Therapeutics Inc
View Trial →
Page 11 of 21 — 522 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology